Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 31, Number 5—May 2025

Research

Postexposure Antimicrobial Drug Therapy in Goats Infected with Burkholderia pseudomallei

Richard A. BowenComments to Author , Airn E. Hartwig, Angela M. Bosco-Lauth, Josilene N. Seixas, Jana M. Ritter, Pamela S. Fair, Mindy G. Elrod, Zachary P. Weiner, Robyn A. Stoddard, Antonio R. Vieira, Rachel M. Maison, Elizabeth Lawrence, Hannah Sueper, Mckinzee Barker, and William A. Bower
Author affiliation: Colorado State University College of Veterinary Medicine and Biomedical Sciences, Fort Collins, Colorado, USA (R.A. Bowen, A.E. Hartwig, A.M. Bosco-Lauth, R.M. Maison, E. Lawrence, H. Sueper, M. Barker); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.N. Seixas, J.M. Ritter, P.S. Fair, M.G. Elrod, Z.P. Weiner, R.A. Stoddard, A.R. Vieira, W.A. Bower)

Main Article

Figure 4

Histopathologic lesions (arrows) and immunocytochemical localization of Burkholderia pseudomallei in spleen and lymph nodes of goats infected with Burkholderia pseudomallei in study of postexposure antimicrobial drug therapy.

Figure 4. Histopathologic lesions (arrows) and immunocytochemical localization of Burkholderia pseudomallei in spleen and lymph nodes of goats infected with Burkholderia pseudomallei in study of postexposure antimicrobial drug therapy.

Main Article

Page created: March 13, 2025
Page updated: April 25, 2025
Page reviewed: April 25, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external